Mineralys Therapeutics (MLYS) Market Cap to FCF (2023 - 2026)
Mineralys Therapeutics (MLYS) Market Cap to FCF (2023 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Market Cap to FCF |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
-5.45 Mn |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
-3.07 Mn |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-39,790.86 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-158,437.06 |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
-8,971.08 |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
30.57 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
-643.95 |
| 10 |
Mineralys Therapeutics |
2.00 Bn |
2.00 Bn |
- |
-14.63 |
| Date | Value |
|---|
| Jun 9, 2026 |
-14.63 |
| Jun 8, 2026 |
-13.67 |
| Jun 5, 2026 |
-14.39 |
| Jun 4, 2026 |
-15.21 |
| Jun 3, 2026 |
-15.22 |
| Jun 2, 2026 |
-17.60 |
| Jun 1, 2026 |
-18.88 |
| May 29, 2026 |
-19.13 |
| May 28, 2026 |
-19.15 |
| May 27, 2026 |
-18.22 |
| May 26, 2026 |
-18.27 |
| May 22, 2026 |
-18.13 |
| May 21, 2026 |
-18.36 |
| May 20, 2026 |
-17.25 |
| May 19, 2026 |
-15.78 |
| May 18, 2026 |
-16.04 |
| May 15, 2026 |
-16.63 |
| May 14, 2026 |
-16.54 |
| May 13, 2026 |
-16.31 |
| May 12, 2026 |
-17.77 |
